Torasemide tablet 10 mg

DRUG2 trials

Sponsors

Pharmtechnology LLC, Berlin-Chemie AG Menarini Group

Conditions

BioequivalenceHealthy Adult Male and Female Volunteers

Phase 1

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

CompletedNCT04921566

Pharmtechnology LLCBioequivalence

Start: 2021-06-05End: 2021-06-20Updated: 2023-06-29

A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

RecruitingNCT07201584

Berlin-Chemie AG Menarini GroupHealthy Adult Male and Female Volunteers

Start: 2025-09-05End: 2026-04-01Target: 26Updated: 2026-01-14